Methyl 6-chloropyridazine-4-carboxylate

Catalog No. :
ACDQRI149
CAS No. :
1093860-48-0
Molecular Formula :
C6H5ClN2O2
Molecular Weight :
172.57

IUPAC Name:methyl 6-chloropyridazine-4-carboxylate

Methyl 6-chloropyridazine-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$58.00Login to see priceIn stockIn stock
10g98%$105.00Login to see priceIn stockIn stock
25g98%$247.00Login to see priceIn stockInquiry
100g98%$958.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 6-chloropyridazine-4-carboxylate
IUPAC Namemethyl 6-chloropyridazine-4-carboxylate
MDL No.MFCD16660968
Molecular FormulaC6H5ClN2O2
Molecular Weight172.57
SMILESClC1=CC(=CN=N1)C(=O)OC
InChI KeyQYQHGLKSLGUINZ-UHFFFAOYSA-N
SynonymCS-W006602 | GS-4227 | FT-0646857 | Methyl 6-chloropyridazine-4-carboxylate | EN300-248457 | DTXSID10672212 | AMY25068 | AKOS015851435 | MFCD16660968 | SY042100 | QYQHGLKSLGUINZ-UHFFFAOYSA-N | Z1255421836 | METHYL6-CHLOROPYRIDAZINE-4-CARBOXYLATE | SCHEMBL
CAS No.1093860-48-0
PubChem CID45790080

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACDQRI149 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRQSF562 route compound structure diagram
    ACRQSF5621256794-24-7 In Stock
  2. Then
  3. ACDQRI149 route product structure diagram
    ACDQRI1491093860-48-0 In Stock
Inquiry

2. ACDQRI149 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACRQSF562 route compound structure diagram
    ACRQSF5621256794-24-7 In Stock
  4. Then
  5. ACDQRI149 route product structure diagram
    ACDQRI1491093860-48-0 In Stock
Inquiry

Comments (0)